Home / Inspections / 696033

FDA Inspection 696033 — AstraZeneca Pharmaceuticals LP

AstraZeneca Pharmaceuticals LP — FEI 2518137

The FDA completed an inspection of AstraZeneca Pharmaceuticals LP on November 10, 2010 in Wilmington, DE. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 10, 2010
Fiscal Year
2011
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Wilmington, DE (United States)

Additional Details

Sponsor, Contract Research Organization

Facility

Other inspections at this facility

  • 1247294 (NAI Fri Oct 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1219696 (NAI Wed Sep 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 930780 (NAI Fri Jun 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 895234 (NAI Tue Aug 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 873394 (NAI Mon Apr 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources